skip to content
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Hi 5i Team,

I am looking at APTX Aptinyx Inc., a Biopharmaueutical Co., and am thinking to initiate a small position of it.

They are still losing money and did a financing at 3.00 in mid January, but share jumped up to 4.60 already last Friday.

What is your thought and outlook of this company? Is it still speculative ?

Always thank you for your professional advice.
Read Answer Asked by Pui on January 22, 2020
Insiders
Share Information
SEC Filings
News and Media